de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Quantifying the effect of sequence variation on regulatory interactions

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons50420

Manke,  T.
Dept. of Computational Molecular Biology (Head: Martin Vingron), Max Planck Institute for Molecular Genetics, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons50198

Heinig,  M.
Dept. of Computational Molecular Biology (Head: Martin Vingron), Max Planck Institute for Molecular Genetics, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons50613

Vingron,  M.
Gene regulation (Martin Vingron), Dept. of Computational Molecular Biology (Head: Martin Vingron), Max Planck Institute for Molecular Genetics, Max Planck Society;

Locator
There are no locators available
Fulltext (public)

Manke.pdf
(Any fulltext), 304KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Manke, T., Heinig, M., & Vingron, M. (2010). Quantifying the effect of sequence variation on regulatory interactions. Hum Mutation, 31(4), 477-483. doi:10.1002/humu.21209.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0010-7B78-A
Abstract
The increasing amount of sequence data provides new opportunities and challenges to derive mechanistic models that can link sequence variations to phenotypic diversity. Here we introduce a new computational framework to suggest possible consequences of sequence variations on regulatory networks. Our method, called sTRAP (strap.molgen.mpg.de), analyses variations in the DNA sequence and predicts quantitative changes to the binding strength of any transcription factor for which there is a binding model. We have tested the method against a set of known associations between SNPs and their regulatory consequences. Our predictions are robust with respect to different parameters and model assumptions. Importantly we set an objective and quantifiable benchmark against which future improvements can be compared. Given the good performance of our method, we developed a publicly available tool that can serve as an important starting point for routine analysis of disease-associated sequence regions.